Search research articles
Contact Us
Filters
Showing results (181-190 of 303) with videos related to
Page
of 31
Sort By:
Journal of Gastroenterology and Hepatology
|
February 20, 2009
Increased plasma nitric oxide, L-arginine, and arginase-1 in cirrhotic patients with progressive renal dysfunction
Zeid Kayali, Jason Herring, Pedro Baron, et al.
Cancer Research
|
October 1, 2009
Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro
Andrea E Wahner Hendrickson, Paul Haluska, Paula A Schneider, et al.
Arthritis Care & Research
|
April 26, 2016
Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus
Angela George, Andrew Wong-Pack, Christine A Peschken, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 14, 2015
Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based Survey
Eun-Ju Lee, B Douglas Smith, Jessica W Merrey, et al.
Blood
|
July 22, 2006
Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors
Mark Levis, Patrick Brown, B Douglas Smith, et al.
The Journal of Biological Chemistry
|
August 19, 2007
Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization
Xue Wei Meng, Sun-Hee Lee, Haiming Dai, et al.
Arthritis and Rheumatism
|
November 1, 2008
Assessment of reproductive history in systemic sclerosis
Sasha Bernatsky, Marie Hudson, Janet Pope, et al.
Journal of Cellular Biochemistry
|
May 23, 2014
Osteoblasts protect AML cells from SDF-1-induced apoptosis
Kimberly N Kremer, Amel Dudakovic, Meghan E McGee-Lawrence, et al.
The Journal of Rheumatology
|
November 17, 2010
Medication use in systemic lupus erythematosus
Sasha Bernatsky, Christine Peschken, Paul R Fortin, et al.
Haematologica
|
December 24, 2013
A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms
Joshua F Zeidner, Judith E Karp, Amanda L Blackford, et al.
Page
of 31
Search research articles
Search
Showing results (181-190 of 303) with videos related to
Sort By:
Page
of 31
Journal of Gastroenterology and Hepatology
|
February 20, 2009
Increased plasma nitric oxide, L-arginine, and arginase-1 in cirrhotic patients with progressive renal dysfunction
Zeid Kayali, Jason Herring, Pedro Baron, et al.
Cancer Research
|
October 1, 2009
Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro
Andrea E Wahner Hendrickson, Paul Haluska, Paula A Schneider, et al.
Arthritis Care & Research
|
April 26, 2016
Influence of Education on Disease Activity and Damage in Systemic Lupus Erythematosus: Data From the 1000 Canadian Faces of Lupus
Angela George, Andrew Wong-Pack, Christine A Peschken, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 14, 2015
Patterns of Venous Thromboembolism Prophylaxis During Treatment of Acute Leukemia: Results of a North American Web-Based Survey
Eun-Ju Lee, B Douglas Smith, Jessica W Merrey, et al.
Blood
|
July 22, 2006
Plasma inhibitory activity (PIA): a pharmacodynamic assay reveals insights into the basis for cytotoxic response to FLT3 inhibitors
Mark Levis, Patrick Brown, B Douglas Smith, et al.
The Journal of Biological Chemistry
|
August 19, 2007
Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization
Xue Wei Meng, Sun-Hee Lee, Haiming Dai, et al.
Arthritis and Rheumatism
|
November 1, 2008
Assessment of reproductive history in systemic sclerosis
Sasha Bernatsky, Marie Hudson, Janet Pope, et al.
Journal of Cellular Biochemistry
|
May 23, 2014
Osteoblasts protect AML cells from SDF-1-induced apoptosis
Kimberly N Kremer, Amel Dudakovic, Meghan E McGee-Lawrence, et al.
The Journal of Rheumatology
|
November 17, 2010
Medication use in systemic lupus erythematosus
Sasha Bernatsky, Christine Peschken, Paul R Fortin, et al.
Haematologica
|
December 24, 2013
A phase II trial of sequential ribonucleotide reductase inhibition in aggressive myeloproliferative neoplasms
Joshua F Zeidner, Judith E Karp, Amanda L Blackford, et al.
Page
of 31